A61K 9/2826
Sugars or sugar alcohols
Official title: {Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof}
A61K9/2826 (Sugars or sugar alcohols) appears on 186 US grants and 329 published applications in this corpus.
Search patents in A61K- Granted patents
- 186
- Published applications
- 329
- Assignees
- 169
- Inventors
- 697
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 4 | 5 |
| 2003 | 7 | 23 |
| 2004 | 2 | 28 |
| 2005 | 7 | 23 |
| 2006 | 5 | 6 |
| 2007 | 8 | 7 |
| 2008 | 1 | 8 |
| 2009 | 3 | 7 |
| 2010 | 3 | 4 |
| 2011 | 6 | 18 |
| 2012 | 3 | 10 |
| 2013 | 5 | 10 |
| 2014 | 11 | 14 |
| 2015 | 5 | 13 |
| 2016 | 5 | 10 |
| 2017 | 8 | 15 |
| 2018 | 8 | 9 |
| 2019 | 5 | 15 |
| 2020 | 12 | 12 |
| 2021 | 13 | 18 |
| 2022 | 10 | 12 |
| 2023 | 5 | 16 |
| 2024 | 4 | 18 |
| 2025 | 5 | 13 |
| 2026 | 5 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Pharmaceutical composition of darolutamide28 Apr 2026US 12,611,397 B1Orion Corporation
- Tableted cannabinoid chewing gum with tableted modules24 Mar 2026US 12,582,602 B2NordicCan A/S
- Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione17 Mar 2026US 12,576,034 B2Amgen Inc.
- Polypeptide formulations for oral delivery27 Jan 2026US 12,533,321 B2Bhami's Research Laboratory, Pvt. Ltd.
- Natural aqueous film-forming composition based on a pair of starches1 Oct 2026US 2026/0294815 A1Swiss Applied Coating Research GmbH
- Methods of treating erythropoietic protoporphyria or x-linked protoporphyria with bitopertin1 Oct 2026US 2026/0294899 A1Disc Medicine, Inc.
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
- Delayed timed release pharmaceutical composition, preparation method therefor, and use thereof10 Sep 2026US 2026/0263349 A1Shanghai Wd Pharmaceutical Co., Ltd
- Formulations of (+)-2-[1-(3-ethoxy-4- methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione27 Aug 2026US 2026/0248727 A1Amgen Inc.
Most cited
By later US patents
- Pharmaceutical delivery system309US 4,687,660 ABurroughs Wellcome Co. · 1987
- Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations234US 6,046,177 ACydex, Inc. · 2000
- Membrane-coated sustained-release tablets and method151US 4,557,925 AAB Ferrosan · 1985
- Pharmaceutical tablets releasing the active substance after a definite period of time85US 5,464,633 AJagotec AG · 1995
- Controlled release morphine preparation81US 5,520,931 AGacell Laboratories AB · 1996